Generic Name and Formulations:
Sinecatechins 15%; oint.
Indications for VEREGEN:
External genital and perianal warts (Condylomata acuminata) in immunocompetent patients.
≥18yrs: Wash hands. Apply ointment to each wart 3 times daily for up to 16 weeks. Do not cover treated area.
<18yrs: not recommended.
Do not use on internal or mucous membrane warts or on broken skin. Caution with tampon insertion (avoid inadvertent internal application). Wash ointment off if severe reaction occurs. Avoid sexual contact with ointment on skin. Immunosuppressed. May stain fabrics. Avoid sun, UV light on treated area. Pregnancy (Cat.C). Nursing mothers.
Concomitant use of condoms or diaphragm: not recommended (ointment may weaken rubber).
Local reactions (eg, erythema, erosion, edema, itching, burning), phimosis, inguinal lymphadenitis, urethral meatal stenosis, dysuria, rash, desquamation, bleeding, hypersensitivity, superinfection.
Endocrinology Advisor Articles
- AUA: New Guidelines for Diagnosis, Management of Testosterone Deficiency
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Canagliflozin May Improve Renal Outcomes in Patients With Type 2 Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes
- Diabetes Treatments
- ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
- Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Risk Factors for Cardiovascular Disease in Youth With Type 1 Diabetes
- USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention
- Obesity Risk in Infants Born to Women With Diabetes
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Oxyntomodulin Augments Glucose Homeostasis